Clinical Trial Update: Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the combination of oxaliplatin and fluorouracil for recurrent ovarian cancer; the current status of the trial is listed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Eloxatin (oxaliplatin)

Snippet

Sponsor: University of Leicester | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN